Hi Guest
X
Real-Time Quote
Enter Company or MFRanbaxy Laboratories Ltd. - Research Center
Results |
Quarterly
|
Statement | |
More |
(Rs crore)
Quarterly results in brief
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Sales | 1,352.46 | 1,093.78 | 822.13 | 1,012.72 | 1,132.82 |
| Operating profit | 287.10 | 59.37 | -265.26 | -279.61 | 85.46 |
| Interest | 5.90 | -177.49 | 13.33 | 206.65 | 361.11 |
| Gross profit | 293.93 | 264.67 | -237.24 | -424.47 | -260.37 |
| EPS (Rs) | 4.43 | 16.07 | -18.50 | -19.19 | -9.43 |
Quarterly results in details
| Sep ' 09 | Jun ' 09 | Mar ' 09 | Dec ' 08 | Sep ' 08 | |
|---|---|---|---|---|---|
| Other income | 12.73 | 27.81 | 41.35 | 61.79 | 15.28 |
| Stock adjustment | 37.46 | -24.67 | -100.70 | -25.33 | -101.90 |
| Raw material | 348.85 | 415.22 | 363.12 | 308.14 | 424.29 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 147.90 | 179.46 | 145.74 | 106.03 | 129.00 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | 97.23 | 104.68 | 123.30 | 112.63 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 531.15 | 367.18 | 574.55 | 780.19 | 483.34 |
| Provisions made | - | - | - | - | - |
| Depreciation | 31.68 | 31.54 | 29.01 | 33.75 | 30.26 |
| Taxation | 68.36 | 364.37 | -407.27 | -435.97 | -181.84 |
| Net profit / loss | 186.08 | 675.45 | -777.78 | -806.55 | -352.93 |
| Extra ordinary item | - | 806.69 | -918.80 | -784.30 | -244.14 |
| Prior year adjustments | -7.81 | - | - | - | - |
| Equity capital | 210.19 | 210.19 | 210.19 | 210.19 | 187.04 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 1453.33 | 1455.29 | 1452.00 | 1444.31 | 2385.60 |
| Agg.of non promotoholding (%) | 34.57 | 34.62 | 34.54 | 34.36 | 63.77 |
| OPM (%) | 21.23 | 5.43 | -32.27 | -27.61 | 7.54 |
| GPM (%) | 21.53 | 23.60 | -27.47 | -39.50 | -22.68 |
| NPM (%) | 13.63 | 60.22 | -90.07 | -75.06 | -30.74 |